Tap, W. D., Gelderblom, H., Palmerini, E., Desai, J., Bauer, S., Blay, J., Alcindor, T., Ganjoo, K., Martín-Broto, J., Ryan, C. W., Thomas, D. M., Peterfy, C., Healey, J. H., van de Sande, M., Gelhorn, H. L., Shuster, D. E., Wang, Q., Yver, A., Hsu, H. H., Lin, P. S., Tong-Starksen, S., Stacchiotti, S., Wagner, A. J., & , (2019). pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial. Lancet, 394(10197), 478–487. http://access.bl.uk/ark:/81055/vdc_100089543188.0x000053